Crude garlic extract significantly inhibits replication of grapevine viruses

Efforts to control viral diseases of grapevine include the production of certified material and development of virus-resistant transgenic grapevines. However, effective antiviral agents, once the viruses have infected the plants, are still lacking. This study shows that a crude garlic extract has significant antiviral activity against grapevine viruses. Replication of grapevine leafroll-associated virus 2 (GLRaV-2) was obviously inhibited in grapevine cv. Cabernet Sauvignon calli treated with diluted (1:100) garlic extract. The relative RNA levels of GLRaV-2 and grapevine fleck virus (GFkV) in cv. Summer Black grapevine in in vitro-grown plantlets 10 days after treatment with diluted (1:100) garlic extract were about 22% and 20%, respectively, of that in controls. The viral RNA accumulation of GLRaV-2, GFkV, grapevine virus A (GVA), grapevine fanleaf virus (GFLV) and grapevine rupestris stem pitting-associated virus (GRSPaV) in field-grown grapevine cv. Centennial Seedless plants sprayed with diluted (1:100) garlic extract were about 31–40%, 26–38%, 18–31%, 17–42% and 15–18%, respectively, of that in controls. Moreover, the garlic extract treatment led to a significant decrease in viral RNA accumulation of GLRaV-3, GLRaV-2, GVA, GFkV, GFLV, GRSPaV and grapevine Pinot Gris virus in pot-grown grapevine cv. Shine Muscat plants, and viral disease symptoms in these plants were obviously attenuated. In addition, this extract significantly induced expression of pathogenesis-related protein genes and stimulated activity of antioxidant enzymes in grapevines. Taken together, these results indicate that the crude garlic extract acts as a significant inhibitor against a broad range of grapevine viruses.     

一例湖羊纤维素性肺炎的病理组织学观察

为探究四川省某养殖场湖羊患病情况,以1只发病湖羊为例,研究观察病羊临床症状、解剖变化,采用H.E.染色方法分析病羊实质器官病理组织学变化,并从病羊中分离出菌株Z-1,采用生理生化、16S rDNA基因测序对其鉴定,采用腹腔注射对菌株Z-1进行动物回感试验,纸片扩散法对菌株Z-1进行药敏分析。结果表明:患病羊病症有高热、剧烈咳嗽并伴有喘气,口鼻周围可见黄色浓稠分泌物;解剖变化为多个实质器官明显肿大、充血,肺脏充血、颜色暗红,切开有血样泡沫状液体流出;病理组织切片可见肺、肝、脾等组织细胞肿胀、充血、出血,肺泡腔和细支气管中有大量粉红色纤维素性渗出物,炎性细胞浸润;菌株Z-1为革兰氏阳性菌,乳糖、七叶苷和山梨醇等生化反应呈阳性反应,木糖醇、甘露糖和蜜二糖等生化反应呈阴性反应;16S rDNA基因目的片段长度为1 428bp,与菌株NR_026471的相似性达到98%,综合鉴定为链球菌;动物回感试验表明该菌株对小鼠具有很强的致病性;药敏试验表明该菌株对氧氟沙星、诺氟沙星、环丙沙星和庆大霉素等敏感,对氨苄西林、青霉素和拉氧头孢等耐药。综上,该病湖羊患链球菌感染的纤维素性肺炎。     

乌鲁木齐市冬春两季宠物源葡萄球菌的耐药性及耐药基因比较

采用琼脂稀释法,检测从乌鲁木齐市部分宠物医院冬季和春季分离鉴定的154株宠物源葡萄球菌(冬季75株、春季79株)对临床常用的12种抗菌药物(阿米卡星、克林霉素、硫酸庆大霉素、氟苯尼考、四环素、利福平、恩诺沙星、青霉素、苯唑西林、阿莫西林/克拉维酸、头孢噻呋、左氧氟沙星)的耐药性;通过卡方检验,比较供试菌耐药性差异;采用PCR方法,检测葡萄球菌的5类9种耐药基因。对抗菌药物的耐药结果显示:冬季葡萄球菌对苯唑西林和青霉素的耐药率高于90.0%,对头孢噻呋和四环素的耐药率高于50.0%;春季葡萄球菌对左氧氟沙星耐药率达92.4%,对苯唑西林和氟苯尼考耐药率高于80.0%。卡方检验结果显示:冬季葡萄球菌仅对苯唑西林的耐药率显著高于春季葡萄球菌(P0.05);春季葡萄球菌对氟苯尼考、利福平、左氧氟沙星、恩诺沙星和阿莫西林/克拉维酸的耐药率均显著高于冬季葡萄球菌(P0.05)。多药耐药差异性结果显示:冬季葡萄球菌多药耐药集中在1～3耐;春季葡萄球菌多药耐药集中在4、6、9耐。基因检测结果显示:冬季葡萄球菌主要检出的基因有ermB(40.0%,30/75)和fexA(22.7%,17/75);春季葡萄球菌主要检出的基因有fexA(39.3%,31/79)和femA(20.3%,16/79),冬、春季葡萄球菌均未检出cfr、fexB和tetA基因。     

沉淀法制备的紫杉醇白蛋白微粒包封率测定

采用沉淀法制备紫杉醇白蛋白微粒,采用高效液相色谱法(HPLC)测定紫杉醇质量浓度,以二氯甲烷为有机相,采用萃取法分离白蛋白微粒与游离药物,测定其包封率。结果表明:紫杉醇在10~100 mg·L-1范围内线性良好,平均回收率可达到97.6%~101.0%;有机溶剂萃取法测定紫杉醇白蛋白微粒包封率的平均回收率,达94.80%~101.67%。这种方法测定紫杉醇白蛋白微粒回收率准确可靠,适用于沉淀法制备的白蛋白微粒的包封率测定。     

基于最新诊疗方案中抗新型冠状病毒药物的回顾分析与药学监护

2019年12月以来,湖北武汉爆发由新型冠状病毒引发的病毒性肺炎疫情并迅速蔓延,现已确认该新型病毒为SARS-CoV-2.由于目前针对该病毒尚无确切有效的抗病毒药物,给我国公共卫生事业带来了严峻的考验.随着疫情的发展,国家卫生健康委员会下发了最新的《新型冠状病毒肺炎诊疗的方案(试行第七版)》.该文从临床药学角度对最新诊疗方案中所涉及的抗病毒药物进行回顾分析,提出药学监护的重点,并对潜在有效的药物进行展望,以期为抗击新型冠状病毒疫情提供药物使用参考.     

木醋液在农业病虫草防控中的应用研究进展

为了开发木醋液作为优质生物农药的应用价值,本文归纳了不同原材料制作的木醋液在细菌真菌病害、病毒病、根结线虫病、害虫和杂草防除中的应用研究案例。总结了木醋液分别在病虫草防治中的作用：在适当浓度下,对真菌、细菌和根结线虫皆能有效抑制;作为助剂也能用于防治植物病毒病;对害虫具有驱避作用,浓度高时,直接的毒杀效果也很明显;对于作物田的部分杂草种类,木醋液具有被开发为生物除草剂的潜能。同时简单介绍了木醋液对有害生物的作用机理,指出了木醋液作为生物农药具有原材料来源广泛、广谱有效、环境友好、不易导致抗性发展等特点,其作为生物农药具有极大的应用价值。最后指出,在今后应用研发中应分馏纯化、组合复配木醋液产品,实现机制研究和产品标准化的综合目标。     

A New Bioassay Platform Design for the Discovery of Small Molecules with Anticancer Immunotherapeutic Activity

Immunotherapy takes advantage of the immune system to prevent, control, and eliminate neoplastic cells. The research in the field has already led to major breakthroughs to treat cancer. In this work, we describe a platform that integrates in vitro bioassays to test the immune response and direct antitumor effects for the preclinical discovery of anticancer candidates. The platform relies on the use of dendritic cells that are professional antigen-presenting cells (APC) able to activate T cells and trigger a primary adaptive immune response. The experimental procedure is based on two phenotypic assays for the selection of chemical leads by both a panel of nine tumor cell lines and growth factor-dependent immature mouse dendritic cells (D1). The positive hits are then validated by a secondary test on human monocyte-derived dendritic cells (MoDCs). The aim of this approach is the selection of potential immunotherapeutic small molecules from natural extracts or chemical libraries.     

肯塔基沙门菌对氟喹诺酮和碳青霉烯类药物耐药性研究进展

肯塔基沙门菌（Salmonella Kentucky）是继鼠伤寒沙门菌和肠炎沙门菌后又一与人类肠道疾病相关的沙门菌血清型，因其获得和传播耐药性的能力较强而逐渐引起关注。该血清型沙门菌按照多位点序列分型分得的众多亚型中，ST198血清亚型具有易获得耐药突变的基因组岛的特性，21世纪以来不断进化，除获得常见抗菌药物耐药基因外，还相继获得对氟喹诺酮类和碳青霉烯类药物的耐药性并扩散全球，造成临床上难以治疗的病例而引起世界卫生组织的关注。作者整理了肯塔基沙门菌的进化历程，着重阐述肯塔基沙门菌关于氟喹诺酮类及碳青霉烯类药物的耐药情况及耐药机制，以期为中国沙门菌的实验室防控监测系统提供理论依据。     

Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes

The marine environment is a rich source of biologically active molecules for the treatment of human diseases, especially cancer. The adaptation to unique environmental conditions led marine organisms to evolve different pathways than their terrestrial counterparts, thus producing unique chemicals with a broad diversity and complexity. So far, more than 36,000 compounds have been isolated from marine micro- and macro-organisms including but not limited to fungi, bacteria, microalgae, macroalgae, sponges, corals, mollusks and tunicates, with hundreds of new marine natural products (MNPs) being discovered every year. Marine-based pharmaceuticals have started to impact modern pharmacology and different anti-cancer drugs derived from marine compounds have been approved for clinical use, such as: cytarabine, vidarabine, nelarabine (prodrug of ara-G), fludarabine phosphate (pro-drug of ara-A), trabectedin, eribulin mesylate, brentuximab vedotin, polatuzumab vedotin, enfortumab vedotin, belantamab mafodotin, plitidepsin, and lurbinectedin. This review focuses on the bioactive molecules derived from the marine environment with anticancer activity, discussing their families, origin, structural features and therapeutic use.     

微流控芯片在农产品安全检测中的应用

近年来,随着食品工业的迅猛发展,国内外食品安全事故也频繁发生。开发安全可靠、便携有效的检测方法对食品安全至关重要。微流控芯片集样品前处理、分离和检测等过程为一体,实现了样品前处理和检测分析的自动化、集成化、小型化、低消耗、高效率和便携化,满足了现场、实时检测的需求。本研究对微流控芯片在食品成分、农药残留、兽药残留、食品添加剂和重金属检测中的应用进行归纳总结,为农产品安全检测提供参考。